Clinical trial
Dopaminergic Modulation of Declarative Memory
NCT03151460 is registered in ClinicalTrials.gov with I.R.C.C.S. Fondazione Santa Lucia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dopaminergic Modulation of Declarative Memory
- Lead sponsor
- I.R.C.C.S. Fondazione Santa Lucia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- April 30, 2016
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease